Cxbladder Triage 膀胱癌篩查檢測

Cxbladder Triage 是一種非侵入性的分子診斷測試，旨在協助臨床醫生排除膀胱癌，為您和您的患者提供更大的安心。

Cxbladder Triage 的設計目的是利用專有算法結合表型和基因型因素，通過分離指數 ‘G+P INDEX’ 來識別患有尿路上皮癌 (UC) 機率低的患者。使用 G+P INDEX，Cxbladder Triage 專注於準確識別患有血尿且 UC 機率低的患者，這些患者可能不需要進行更廣泛的評估。

Cxbladder Triage 已在一項包含 587 名出現肉眼血尿患者的臨床研究中得到驗證。該研究顯示，Cxbladder Triage 的敏感性為 95.1%，且具有 98.5% 的高陰性預測值，40% 的患者被準確地分流為 UC 機率低。Cxbladder Triage 尤其適合對出現血尿的低風險患者進行分流[1]。

Cxbladder Triage is a non-invasive molecular diagnostic test to assist clinicians in ruling out bladder cancer – giving you and your patients greater peace of mind.

Cxbladder Triage is designed to identify patients with a low probability of having urothelial carcinoma (UC) using a proprietary algorithm combining both phenotypic and genotypic factors into a segregation index – ‘the G+P INDEX’. Using the G+P INDEX, Cxbladder Triage focuses on accurately identifying patients with hematuria who have a low probability of UC, for whom a more extensive evaluation may not be required.

Cxbladder Triage has been validated in a clinical study with 587 patients presenting with gross hematuria. With a sensitivity of 95.1% and high negative predictive value of 98.5%, the study showed that 40% of patients were accurately triaged out with a low probability of UC. Cxbladder Triage is particularly appropriate for triaging low risk patients presenting with hematuria[1].

Reference:

[1] Kavalieris et al: ‘A segregation index combining phenotypic (clinicalcharacteristics) and genotypic (gene expression) biomarkers from a urinesample to triage-out patients presenting with hematuria who have a lowprobability of urothelial carcinoma. BMC urology 2015; 15:23.

＊此測試報告暫只提供英文版本。

在系統確認您的訂單後，尿液收集器將會在兩至三個工作天內以順豐快遞寄出至您登記的地址。

請注意，留小便應早上起牀後，把第一次小便排清，然後只喝清水，待第二次小便才留取。

有關尿液樣本收集的步驟，請查閱收集套組內的說明書，或觀看此教學影片： https://youtu.be/H8SjxSqT4as

如有任何疑問，歡迎於辦公時間內致電3008 2560查詢。